Aevi Genomic Medicine, Inc. License Agreements
7 Contracts & Agreements
- Option and License Agreement, dated as of August 6, 2019, by and between Aevi Genomic Medicine, Inc. and MedImmune Limited (Filed With SEC on November 14, 2019)
- Exclusive License Agreement, dated as of July 15, 2019, by and between Aevi Genomic Medicine, Inc. and OSI Pharmaceuticals, LLC (Filed With SEC on August 13, 2019)
- Amendment No. 3 to License Agreement, dated as of August 12, 2019, by and between Medgenics Medical Israel Ltd. and The Children's Hospital of Philadelphia (Filed With SEC on August 13, 2019)
- Amendment No. 2 to License Agreement, dated March 29, 2019, by and between Medgenics Medical Israel Ltd. and the Childrens Hospital of Philadelphia (Filed With SEC on May 14, 2019)
- Amendment No. 1 to License Agreement, dated March 29, 2019, by and between neuroFix LLC and the Childrens Hospital of Philadelphia (Filed With SEC on May 14, 2019)
- AMENDMENTNO. 1 TO LICENSE AGREEMENT (Filed With SEC on May 10, 2017)
- LICENSE AGREEMENT BY AND BETWEEN THE CHILDREN’S HOSPITAL OF PHILADELPHIA AND MEDGENICS MEDICAL ISRAEL LTD. (Filed With SEC on February 13, 2015)
